A Lopinavir/Ritonavir-Based Once-Daily Regimen Results in Better Compliance and Is Non-inferior to a Twice-Daily Regimen Through 96 Weeks
AIDS research and human retroviruses, 2007-12, Vol.23 (12), p.1505-1514 [Peer Reviewed Journal]2008 INIST-CNRS ;COPYRIGHT 2007 Mary Ann Liebert, Inc. ;ISSN: 0889-2229 ;EISSN: 1931-8405 ;DOI: 10.1089/aid.2007.0107 ;PMID: 18160008 ;CODEN: ARHRE7
Full text available